MYOPIA MANAGEMENT
At Johnson & Johnson Vision, we're committed to providing you the resources and tools you need to successfully manage myopia in your patients. Learn more about myopia and how ACUVUE® Abiliti™ can be part of your practice.
We're committed to providing innovative, evidence-based options for myopia management with unparalleled support for you and your staff.
The Abiliti™ Family of products for myopia control features innovative products that can be customized to your patients’ lifestyle
Benefit from highly-trained Abiliti™ Clinical Consultants and in-house orthokeratology experts by your side. Gain access to tailored, comprehensive modules created alongside Myopia Profile—an industry education leader—for you and your staff. Learn from immersive Master Your Abiliti™ workshops and Centres of Excellence visits which are designed to enhance your clinical practice.1:1 attention
Educational framework
Hands-on training
*Compared to single- vision spectacles 1. Holden BA Fricke TR Wilson DA Jong M Naidoo K et al Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 to 2050. Ophthalmol 2016,123(5):1036-1042 2. Data on File 2023. Menicon Design History file 3. Cho P, Cheung SW. Retardation of myopia in Orthokeratology (ROMIO) study: a 2-year randomized clinical trial. Invest Ophthalmol Vis Sci [Internet]. 2012/09/13. 2012;53(11):7077–85. 4. Santodomingo- Rubido J, Villa-Collar C, Gilmartin B, Gutiérrez-Ortega R. Myopia control with orthokeratology contact lenses in Spain: Refractive and biometric changes. Invest Ophthalmol Vis Sci. 2012;53(8). 5. Chen C, Cheung SW, Cho P. Myopia control using toric orthokeratology (TO-SEE study). Invest Ophthalmol Vis Sci [Internet]. 2013/09/05. 2013;54(10):6510–7. 6. JJV Data on File 2021. Development of Optical Design of ACUVUE® Abiliti™ 1-Day Soft Therapeutic Lenses for Myopia Management. Important Safety information: ACUVUE® AbilitiTM Overnight Therapeutic (tisilfocon A) Contact Lenses are indicated for use in the control of myopia. They are indicated for overnight wear for the temporary reduction of myopia and should only be disinfected using a chemical disinfection system. As with any contact lens, eye problems, including corneal ulcers, can develop. Some wearers may experience mild irritation, itching or discomfort. These lenses should not be prescribed if patients have any eye infection, or experience eye discomfort, excessive tearing, vision changes, redness, other eye problems, or if patients have any allergy to any ingredient in a solution which is to be used to care for these lenses. Complete information is also available from Johnson & Johnson Vision Care, Inc. by calling 1-877-334-3937, option 4, or by visiting www.seeyourabiliti.com Important Safety information: Acuvue® AbilitiTM 1- Day Soft Therapeutic Lenses for Myopia Management are available by prescription only for the correction of myopia (while the lenses are worn) and may slow the progression of myopia in children (7-12 years old). As with any contact lens, eye problems, including corneal ulcers, can develop. Some wearers may experience mild irritation, itching or discomfort. These lenses should not be prescribed if patients have any eye infection, or experience eye discomfort, excessive tearing, vision changes, redness, other eye problems. Due to the intended optical design of these lenses for the purpose of reducing the patient’s prescription change, these lenses will provide vision correction while worn, but the vision quality may not be as clear as with conventional soft contact lenses. Patients should exercise extra care if performing potentially hazardous, vision demanding activities. Complete information is also available from Johnson & Johnson Vision Care, Inc. by calling 1-877-334-3937, option 4, or Visit www.seeyourabiliti.com
We support the AdvaMed Code of Ethics on interacting with Healthcare Professionals.
Overview
Useful Links
Legal
Additional Information
© Johnson & Johnson Vision Care, Inc. and Johnson & Johnson Surgical Vision, Inc. 2024 All rights reserved. This site is published by Johnson & Johnson Vision Care, Inc. and Johnson & Johnson Surgical Vision, Inc., which are solely responsible for its content.
Third party trademarks used herein are trademarks of their respective owners.
Vision Made Possible™
